Skip to main content

HOSPITAL

07/03/2022

IMIDomics announced equity investment from the company Evotec

Sara Marsal

07/03/2022

IMIDomics is a privately held global biotechnology company focused on the discovery and development of novel targets and drugs for the treatment of patients with immune-mediated inflammatory diseases.

IMIDomics, a Vall d'Hebron spin-off founded in 2015 by Dr. Sara Marsal, head of the Rheumatology Service at Vall d'Hebron University Hospital and head of the Rheumatology research group at Vall d'Hebron Research Institute, has received an equity investment from Evotec SE, a world leader in drug development.

IMIDomics is a privately held global biotechnology company focused on the discovery and development of new targets and drugs for the treatment of patients with immune-mediated inflammatory diseases (IMIDs). Last June it completed a $16.5 million financing round in which DNS Capital, Bristol Myers Squibb, The Pritzker Organization and TAO Capital, among others, participated.

This new investment will further advance IMIDomics’ Precision Discovery™ Engine which enables a deep understanding of how IMIDs work within patients via a combination of clinical and computational expertise with patient biological samples from the Vall d’Hebron Hospital IMID Biobank, exclusive access to curated, secure and anonymized clinical data collected from more than 17,000 IMID patients and control subjects from across 150 health centers, and proprietary biomolecular signatures generated by IMIDomics from these same patients. Ultimately, the Engine’s purpose is to discover medicines that will materially impact IMID patients’ lives.

Related news

Onze investigadors i investigadores de Vall d’Hebron faran xerrades i tallers amb l’objectiu d’apropar la ciència a tothom.

The research led by Dr. José Alegre has been one of the 21 projects selected in the 19th call for Health Research Grants.

The jury has valued its ability to raise international funds during 2021 and its trajectory as an example of the translation from the clinic to a company.

Related professionals

Jesus Castro Marrero

Jesus Castro Marrero

Postdoctoral researcher
Rheumatology
Read more
Maria Royo Lopez

Maria Royo Lopez

Research technician
Rheumatology
Read more
Irene Bonafonte Pardàs

Irene Bonafonte Pardàs

Research technician
Rheumatology
Read more
Ana Tirado Esteban

Ana Tirado Esteban

Research technician
Rheumatology
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.